Dongyang Liu (Cheng Cui)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Body Mass Index

Acute Coronary Syndrome

St Elevation Myocardial Infarction

Top Venues

Clinical pharmacokinetics

Clinical pharmacology and therapeutics

Diabetes, obesity & metabolism

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jingcheng Chen, Yuchen Qu, Muhan Jiang, Haiyan Li, Cheng Cui, Dongyang Liu
Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation. Clinical pharmacokinetics 63 (3) (2024)
Jingcheng Chen, Yuchen Qu, Muhan Jiang, Haiyan Li, Cheng Cui, Dongyang Liu
Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation. Clinical pharmacokinetics 63 (3) (2024)
Yafen Li, Xiaonan Li, Miao Zhu, Huan Liu, Zihan Lei, Xueting Yao, Dongyang Liu
Development of a Physiologically Based Pharmacokinetic Population Model for Diabetic Patients and its Application to Understand Disease-drug-drug Interactions. Clinical pharmacokinetics 63 (6) (2024)
Jingcheng Chen, Yuchen Qu, Muhan Jiang, Haiyan Li, Cheng Cui, Dongyang Liu
Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation. Clinical pharmacokinetics 63 (3) (2024)
Yafen Li, Xiaonan Li, Miao Zhu, Huan Liu, Zihan Lei, Xueting Yao, Dongyang Liu
Development of a Physiologically Based Pharmacokinetic Population Model for Diabetic Patients and its Application to Understand Disease-drug-drug Interactions. Clinical pharmacokinetics (2024)
Jingcheng Chen, Yuchen Qu, Muhan Jiang, Haiyan Li, Cheng Cui, Dongyang Liu
Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation. Clinical pharmacokinetics 63 (3) (2024)
Jie En Valerie Sia, Xuan Lai, Wen Yao Mak, Xinyi Wu, Fan Zhang, Dongyang Liu, Dongyang Liu, Xiaoqiang Xiang
Aging-Related CYP3A Functional Changes in Chinese Older Patients: New Findings from Model-Based Assessment of Amlodipine. Clinical pharmacology and therapeutics 116 (3) (2024)
Jingcheng Chen, Yuchen Qu, Muhan Jiang, Haiyan Li, Cheng Cui, Dongyang Liu
Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation. Clinical pharmacokinetics (2024)
Jingcheng Chen, Yuchen Qu, Muhan Jiang, Haiyan Li, Cheng Cui, Dongyang Liu
Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation. Clinical pharmacokinetics (2024)
Ling Song, Xiaoxu Wang, Jingfang Sun, Xinyu Hu, Haiyan Li, Pei Hu, Dongyang Liu
A Model-Informed Approach to Accelerate the Clinical Development of Janagliflozin, an Innovative SGLT2 Inhibitor. Clinical pharmacokinetics (2023)
Yaxin Liu, Yun Kuang, Min Hai, Dongyang Liu, Dongyang Liu, Guo-Ping Yang
Model-Informed Dosing Regimen of Ticagrelor in Chinese Patients with Acute Coronary Syndrome. Clinical pharmacology and therapeutics (2023)
Ling Song, Xiaoxu Wang, Jingfang Sun, Xinyu Hu, Haiyan Li, Pei Hu, Dongyang Liu
A Model-Informed Approach to Accelerate the Clinical Development of Janagliflozin, an Innovative SGLT2 Inhibitor. Clinical pharmacokinetics (2023)
Dongyang Liu, Fangrui Cao, Iok Ian Kong, Qinghe Wu, Fangqiong Li, Haiyan Li, Dongyang Liu
A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor. Diabetes, obesity & metabolism (2023)
Ling Song, Fangrui Cao, Shu Niu, Michael Xu, Ruifang Liang, Ke Ding, Zhigang Lin, Xueting Yao, Dongyang Liu
Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China. Clinical pharmacokinetics (2023)
Cheng Cui, Yuchen Qu, Jie En Valerie Sia, Zhu Zhu, Yang Wang, Jing Ling, Haiyan Li, Yan Jiang, Jie Pan, Dongyang Liu
Assessment of Aging-Related Function Variations of P-gp Transporter in Old-Elderly Chinese CHF Patients Based on Modeling and Simulation. Clinical pharmacokinetics (2022)
Dongyang Liu, Jie En Valerie Sia, Siqi Tu, Xiaobei Li, Zhongqi Dong, Zhiheng Yu, Xueting Yao, Oliver Hatley, Haiyan Li, Dongyang Liu
Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects. British journal of clinical pharmacology 87 (7) (2021)
Dongyang Liu, Xiaobei Li, Hao Liang, Zhe Hou, Siqi Tu, Zhongqi Dong, Xueting Yao, Miao Zhang, Xuan Zhang, Haiyan Li, Xiaocong Zuo, Dongyang Liu
Physiologically based pharmacokinetic model of renally cleared antibacterial drugs in Chinese renal impairment patients. Biopharmaceutics & drug disposition 42 (1) (2021)
Dongyang Liu, Jiabei Sun, Xueqing Wang, Zhenxi Yu, Yaqin Shi
Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs. Dose-response : a publication of International Hormesis Society 18 (1) (2020)